My Cart

Integrin alpha E beta 7

Integrin alpha E beta 7 Overview

English NameIntegrin alpha-E/beta-7Approved Drugs0
Drugs in Clinical Trials2Target Synonym
Highest Development StagePhase 3 Clinical
English NameIntegrin alpha-E/beta-7
Target Synonym
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 3 Clinical

Integrin alpha E beta 7 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (1)Cynomolgus (1)Mouse (1)

  • Tag

    His Tag (3)

  • Conjugate

    Unconjugated (3)

Integrin alpha E beta 7 Background

Integrin alpha E beta 7 consist of two major subunits: Integrin alpha E (ITGAE) also known as CD103 (cluster of differentiation 103) and Integrin beta-7 is an integrin protein that in humans is encoded by the ITGB7 gene. Integrin alpha E beta 7 (CD103) is expressed mainly by cells of the T lymphocyte lineage within mucosal tissues. This is a strikingly narrow pattern of expression compared with that of other integrins. Lymphocytes expressing alpha E beta 7 are abundant in the gut and comprise a major part of the total T cell complement of the body. The effectiveness of lung transplantation is marred by the relatively high incidence of rejection. The lung normally contains a large population of lymphocytes in contact with the airway epithelium, a proportion of which expresses the mucosal integrin, alpha(E)(CD103)beta(7). This integrin is not a homing receptor, but is thought to retain lymphocytes at the epithelial surface.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
EtrolizumabPRO-145223; rhuMAb-Beta7; R-7413; RG-7413Phase 3 ClinicalGenentech IncColitis, Ulcerative; Crohn Disease
Details
ABBV-243ABBV-243Phase 1 ClinicalAbbvie Inc
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland